Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RARB | P10826 | 3/20 | 0.39 |
| ▸ | RARA | P10276 | 2/20 | 0.39 |
| ▸ | RARG | P13631 | 1/20 | 0.39 |
| ▸ | CYP17A1 | P05093 | 2/20 | 0.35 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | ESR1 | P03372 | 2/20 | 0.34 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.34 |
| ▸ | FAAH | O00519 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.33 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.33 |
| ▸ | KIF11 | P52732 | 1/20 | 0.33 |
| ▸ | UCHL1 | P09936 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2479271 | 0.85 | RARB (0.36) | RARBRARARARGCYP17A1TAAR1 | |
| SCHEMBL14329412 | 0.84 | RARB (0.43) | RARBRARARARGCYP17A1TAAR1 | |
| SCHEMBL15471662 | 0.84 | RARB (0.43) | RARBRARARARGCYP17A1TAAR1 | |
| SCHEMBL15870436 | 0.82 | RARB (0.43) | RARBRARARARGCYP17A1TAAR1 | |
| SCHEMBL16377214 | 0.82 | RARB (0.43) | RARBRARARARGCYP17A1TAAR1 | |
| SCHEMBL11996454 | 0.78 | RARB (0.43) | RARBRARARARGCYP17A1TAAR1 | |
| SCHEMBL9663272 | 0.78 | RARB (0.43) | RARBRARARARGCYP17A1TAAR1 | |
| SCHEMBL2477723 | 0.78 | RARB (0.41) | RARBRARARARGTAAR1LMNA | |
| SCHEMBL6897375 | 0.77 | RARB (0.40) | RARBRARARARGCYP17A1TAAR1 | |
| SCHEMBL16377219 | 0.76 | ALOX5 (0.40) | RARBRARARARGCYP17A1TAAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1970362-B1 | MONOFLUORINATED TERPHENYL COMPOUND HAVING ALKENYL, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY ELEMENT | JNC CORP (JP) | 2011-10-12 | — | — | EP | disclosed |
| EP-1970362-B1 | MONOFLUORINATED TERPHENYL COMPOUND HAVING ALKENYL, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY ELEMENT | JNC CORP (JP) | 2011-10-12 | — | — | EP | disclosed |
| US-7749403-B2 | Monofluorinated terphenyl compound having alkenyl, liquid crystal composition, and liquid crystal display device | CHISSO CORPORATION (JP) | 2010-07-06 | — | — | US | disclosed |
| US-7749403-B2 | Monofluorinated terphenyl compound having alkenyl, liquid crystal composition, and liquid crystal display device | CHISSO CORPORATION (JP) | 2010-07-06 | — | — | US | disclosed |
| US-20090206300-A1 | MONOFLUORINATED TERPHENYL COMPOUND HAVING ALKENYL, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE | JIANGSU HECHENG DISPLAY TECHNOLOGY CO., LTD. (CN) | 2009-08-20 | — | — | US | disclosed |
| US-20090206300-A1 | MONOFLUORINATED TERPHENYL COMPOUND HAVING ALKENYL, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE | JIANGSU HECHENG DISPLAY TECHNOLOGY CO., LTD. (CN) | 2009-08-20 | — | — | US | disclosed |
| EP-1970362-A1 | MONOFLUORINATED TERPHENYL COMPOUND HAVING ALKENYL, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY ELEMENT | Chisso Corporation (JP) | 2008-09-17 | — | — | EP | disclosed |
| EP-1970362-A1 | MONOFLUORINATED TERPHENYL COMPOUND HAVING ALKENYL, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY ELEMENT | Chisso Corporation (JP) | 2008-09-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090206300-A1 | MONOFLUORINATED TERPHENYL COMPOUND HAVING ALKENYL, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE | LEF1, FZD7, HTR1D | RARB 3441/4885RARA 2495/4885RARG 3629/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.